Research statistics
ARA 290 (Cibinetide) research: publications and trials
At a glance
Publications, all years
75
Since 2011
Publications in 2026 so far
5
Through November 15, 2026
Human clinical research
10.7%
8 of 75 classified
Registered clinical trials
4
ClinicalTrials.gov
Randomized controlled trials
4
Publications reporting an RCT in people
Systematic reviews and meta-analyses
1
Preclinical studies
68.0%
43 animal · 8 in vitro · 0 computational
Records that only mention it
8
Not counted above
Status in the library: In clinical trials. Groups: Tissue-repair peptides.
Publications by year
ARA 290 (Cibinetide) publications by year and evidence
Show the data
| Year | Human clinical research | Preclinical (animal, in vitro, computational) | Reviews and meta-analyses | Other and not yet classified | Total |
|---|---|---|---|---|---|
| 2011 | 0 | 3 | 0 | 0 | 3 |
| 2012 | 1 | 2 | 0 | 0 | 3 |
| 2013 | 2 | 6 | 2 | 1 | 11 |
| 2014 | 0 | 5 | 2 | 1 | 8 |
| 2015 | 2 | 2 | 2 | 0 | 6 |
| 2016 | 0 | 5 | 2 | 0 | 7 |
| 2017 | 1 | 4 | 0 | 0 | 5 |
| 2018 | 1 | 3 | 0 | 0 | 4 |
| 2019 | 0 | 1 | 0 | 0 | 1 |
| 2020 | 1 | 3 | 0 | 0 | 4 |
| 2021 | 0 | 5 | 0 | 1 | 6 |
| 2022 | 0 | 3 | 0 | 0 | 3 |
| 2023 | 0 | 1 | 0 | 0 | 1 |
| 2024 | 0 | 3 | 1 | 0 | 4 |
| 2025 | 0 | 4 | 0 | 0 | 4 |
| 2026 (to date) | 0 | 1 | 4 | 0 | 5 |
Study types
| Animal study | 43 |
|---|---|
| Review | 12 |
| In vitro study | 8 |
| Randomized controlled trial | 4 |
| Editorial, letter or other | 3 |
| Other clinical trial | 2 |
| Observational human study | 2 |
| Systematic review | 1 |
Research areas
From MeSH major topics. A paper can be in several areas.
| Neurological and mental health | 31 |
|---|---|
| Immune system | 28 |
| Tissue repair | 24 |
| Cardiovascular | 16 |
| Metabolic health | 12 |
| Endocrinology | 11 |
| Cognitive health | 4 |
| Dermatology | 3 |
| Musculoskeletal | 3 |
| Reproductive and sexual health | 3 |
| Gastrointestinal | 2 |
| Antimicrobial and infectious disease | 1 |
Registered clinical trials
0 of 2 trials completed at least a year before the cutoff have neither posted results nor a linked results publication. A registration is not a result.
Completed: 2 · Terminated: 1 · Unknown status: 1
Phase 1 / Phase 2: 1 · Phase 2: 3
| Trial | Status | Phase | Started | Results |
|---|---|---|---|---|
| The Use of ARA290 for the Treatment of Diabetic Macular OedemaNCT06626971 · 9 enrolled | Terminated | Phase 2 | 2016-04 | — |
| Study of Efficacy of ARA 290 on Corneal Nerve Fiber Density and Neuropathic Symptoms of Subjects With SarcoidosisNCT02039687 · 64 enrolled | Completed | Phase 2 | 2014-01 | Posted |
| ARA290 in T2D (Effects of ARA 290, an Erythropoietin Analogue) in Prediabetes and Type 2 Diabetes)NCT01933529 · 24 enrolled | Unknown status | Phase 2 | 2013-10 | — |
| Cognitive and Neural Effects of ARA290NCT02070783 · 36 enrolled | Completed | Phase 1, Phase 2 | 2012-02 | — |
Human trials and evidence reviews
Meta-analyses, systematic reviews and trials in people, newest first.
- Managing fatigue in sarcoidosis - A systematic review of the evidence.
Chronic respiratory disease · August 9, 2016 · Systematic review · cited 40 times · open access
PMID 27507833 · DOI 10.1177/1479972316661926 · Reviews and meta-analyses
- Cibinetide Improves Corneal Nerve Fiber Abundance in Patients With Sarcoidosis-Associated Small Nerve Fiber Loss and Neuropathic Pain.
Investigative ophthalmology & visual science · May 1, 2017 · Randomized controlled trial · cited 104 times · open access
PMID 28475703 · DOI 10.1167/iovs.16-21291 · Human clinical research
- Testing the antidepressant properties of the peptide ARA290 in a human neuropsychological model of drug action.
European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology · September 18, 2015 · Randomized controlled trial · cited 11 times
PMID 26431906 · DOI 10.1016/j.euroneuro.2015.09.005 · Human clinical research
- ARA 290 improves symptoms in patients with sarcoidosis-associated small nerve fiber loss and increases corneal nerve fiber density.
Molecular medicine (Cambridge, Mass.) · November 8, 2013 · Randomized controlled trial · cited 95 times · open access
PMID 24136731 · DOI 10.2119/molmed.2013.00122 · Human clinical research
- Safety and efficacy of ARA 290 in sarcoidosis patients with symptoms of small fiber neuropathy: a randomized, double-blind pilot study.
Molecular medicine (Cambridge, Mass.) · November 15, 2012 · Randomized controlled trial · cited 112 times · open access
PMID 23168581 · DOI 10.2119/molmed.2012.00332 · Human clinical research
- A Phase 2 Clinical Trial on the Use of Cibinetide for the Treatment of Diabetic Macular Edema.
Journal of clinical medicine · July 14, 2020 · Other clinical trial · cited 11 times · open access
PMID 32674280 · DOI 10.3390/jcm9072225 · Human clinical research
- ARA 290, a nonerythropoietic peptide engineered from erythropoietin, improves metabolic control and neuropathic symptoms in patients with type 2 diabetes.
Molecular medicine (Cambridge, Mass.) · March 13, 2015 · Other clinical trial · cited 144 times · open access
PMID 25387363 · DOI 10.2119/molmed.2014.00215 · Human clinical research
Most cited
By OpenAlex citation count. Citations measure attention, not quality or correctness.
- ARA 290, a nonerythropoietic peptide engineered from erythropoietin, improves metabolic control and neuropathic symptoms in patients with type 2 diabetes.
Molecular medicine (Cambridge, Mass.) · March 13, 2015 · Other clinical trial · cited 144 times · open access
PMID 25387363 · DOI 10.2119/molmed.2014.00215 · Human clinical research
- Safety and efficacy of ARA 290 in sarcoidosis patients with symptoms of small fiber neuropathy: a randomized, double-blind pilot study.
Molecular medicine (Cambridge, Mass.) · November 15, 2012 · Randomized controlled trial · cited 112 times · open access
PMID 23168581 · DOI 10.2119/molmed.2012.00332 · Human clinical research
- Co-delivery of a growth factor and a tissue-protective molecule using elastin biopolymers accelerates wound healing in diabetic mice.
Biomaterials · June 30, 2017 · Animal study · cited 106 times
PMID 28688286 · DOI 10.1016/j.biomaterials.2017.06.043 · Animal studies
- Cibinetide Improves Corneal Nerve Fiber Abundance in Patients With Sarcoidosis-Associated Small Nerve Fiber Loss and Neuropathic Pain.
Investigative ophthalmology & visual science · May 1, 2017 · Randomized controlled trial · cited 104 times · open access
PMID 28475703 · DOI 10.1167/iovs.16-21291 · Human clinical research
- ARA 290 improves symptoms in patients with sarcoidosis-associated small nerve fiber loss and increases corneal nerve fiber density.
Molecular medicine (Cambridge, Mass.) · November 8, 2013 · Randomized controlled trial · cited 95 times · open access
PMID 24136731 · DOI 10.2119/molmed.2013.00122 · Human clinical research
Latest publications
- Regenerative peptides for inferior alveolar nerve injury: a narrative review.
Frontiers in dental medicine · October 27, 2026 · Review · cited 0 times · open access
PMID 43011877 · DOI 10.3389/fdmed.2026.1977522 · Reviews and meta-analyses
- Case Report: Regenerative peptides for Inferior alveolar nerve injury: a narrative review with hypothesis-generating three clinical cases.
Frontiers in oral health · September 30, 2026 · Review · cited 0 times · open access
PMID 42876687 · DOI 10.3389/froh.2026.1907109 · Reviews and meta-analyses
- Peptides in Regenerative Medicine: A Comprehensive Review of Clinical Applications in Tissue Repair and Chronic Pain Management.
Current pain and headache reports · August 24, 2026 · Review · cited 0 times
PMID 42635865 · DOI 10.1007/s11916-026-01542-z · Reviews and meta-analyses
- Immunometabolic dysregulation drives selective executive cognitive dysfunction in male db/db mice.
Neurobiology of disease · April 1, 2026 · Animal study · cited 0 times · open access
PMID 41933665 · DOI 10.1016/j.nbd.2026.107376 · Animal studies
- Phase-targeted erythropoietin derivatives for traumatic brain injury: bridging mechanisms to precision therapy.
Frontiers in neurology · January 23, 2026 · Review · cited 0 times · open access
PMID 41659975 · DOI 10.3389/fneur.2025.1665405 · Reviews and meta-analyses
- ARA290 Attenuates Apical Periodontitis via SIRT1/NF-κB/IL-1β Pathway Modulation.
International dental journal · July 17, 2025 · Animal study · cited 5 times · open access
PMID 40680515 · DOI 10.1016/j.identj.2025.100863 · Animal studies
- ARA290, an alternative of erythropoietin, inhibits activation of NLRP3 inflammasome in schwann cells after sciatic nerve injury.
European journal of pharmacology · April 9, 2025 · Animal study · cited 5 times
PMID 40216181 · DOI 10.1016/j.ejphar.2025.177610 · Animal studies
- Mechanisms of ARA290 in counteracting cadmium-triggered neurotoxicity in PC12 cells.
Toxicology research · February 17, 2025 · In vitro study · cited 12 times · open access
PMID 39968520 · DOI 10.1093/toxres/tfaf023 · In vitro studies
- Anti-Inflammatory Effects of Clarstatin, a Shared-Epitope-Antagonistic Cyclic Peptide, on Experimental Autoimmune Uveitis in Mice.
Investigative ophthalmology & visual science · January 1, 2025 · Animal study · cited 2 times · open access
PMID 39775697 · DOI 10.1167/iovs.66.1.13 · Animal studies
- The protective effect of erythropoietin and its novel derived peptides in peripheral nerve injury.
International immunopharmacology · June 28, 2024 · Review · cited 5 times
PMID 38943972 · DOI 10.1016/j.intimp.2024.112452 · Reviews and meta-analyses
How this is counted
PubMed records matched by the names below, counted when the peptide is in the title, indexed by MeSH, or confirmed from the abstract. The exact query can be rerun on Europe PMC. Methodology
Search terms: ARA 290; Cibinetida; Cibinetide; PHβSP
((TITLE_ABS:"ARA 290" OR CHEM:"ARA 290" OR TITLE_ABS:"ARA290" OR CHEM:"ARA290") OR (TITLE_ABS:"Cibinetida" OR CHEM:"Cibinetida") OR (TITLE_ABS:"Cibinetide" OR CHEM:"Cibinetide") OR (TITLE_ABS:"PHβSP" OR CHEM:"PHβSP" OR TITLE_ABS:"PHbetaSP" OR CHEM:"PHbetaSP")) AND SRC:MED
Cite this page
Peptide Library. (2026, November 16). ARA 290 (Cibinetide) research statistics (Version weekly-2026-11-15) [Statistic]. Peptide Library. https://peptidelibrary.app/research/peptides/ara-290